Metraipolis › archive › dc_fc167e30f248

Global pharmacovigilance reporting: comparative analysis of adverse event obligations across five major regulatory authorities — Europe PMC PMID:42180407

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42180407
DOI
10.3389/fdsfr.2026.1821686
License (as archived)
solo-consultazione
Archived
2026-11-02T14:20:54.232Z
SHA-256 of the archived text
0e4e7cf899a121c4ed0157d829ae04605e71a2f4e35da61fcbf1b7b18b0aaca4
Stable URL of this page
https://metraipolis.com/documento/dc_fc167e30f248

How to cite

Global pharmacovigilance reporting: comparative analysis of adverse event obligations across five major regulatory authorities — Europe PMC PMID:42180407 — Europe PMC (en), https://europepmc.org/article/MED/42180407 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fc167e30f248 (Metraipolis archive dc_fc167e30f248, sha256 0e4e7cf899a121c4ed0157d829ae04605e71a2f4e35da61fcbf1b7b18b0aaca4)
BibTeX
@misc{dcfc167e30f248,
  title = {Global pharmacovigilance reporting: comparative analysis of adverse event obligations across five major regulatory authorities — Europe PMC PMID:42180407},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42180407},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fc167e30f248; sha256 0e4e7cf899a121c4ed0157d829ae04605e71a2f4e35da61fcbf1b7b18b0aaca4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42180407. Agents can read the archived copy with the MCP tool read_document.